Skip to main content
SpringerLink
Log in

EULAR* has made recommendations for the monitoring of adverse events of low-dose glucocorticoid therapy in both clinical trials and daily practice.

  • Guideline
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW.Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Annals of the Rheumatic Diseases: 6 Aug 2010. Available from: URL: http://dx.doi.org/10.1136/ard.2009.124958

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

EULAR* has made recommendations for the monitoring of adverse events of low-dose glucocorticoid therapy in both clinical trials and daily practice.. React. Wkly. 1320, 3 (2010). https://doi.org/10.2165/00128415-201013200-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013200-00008

Keywords

Search

Navigation